Skip to main content

Table 3 Comparison of FSFI scores of patients in RATV group and RATA group after PSM

From: Efficacy comparison of optimal natural orifice specimen extraction for robotic middle rectal cancer resection in women: transanal or transvaginal orifice

Domain

All patients

Pre-menopausal

Post-menopausal

RATV (n=29)

RATA (n=34)

P

RATV (n=15)

RATA (n=18)

P

RATV (n=14)

RATA (n=16)

P

Desire

3.6(2.4-4.8)

4.2(3.0-4.8)

0.496

3.0(2.4-4.8)

4.2(3.5-4.8)

0.485

3.9(3.0-4.4)

4.2(2.4-4.8)

0.865

Arousal

3.6(2.4-4.7)

4.2(3.3-4.8)

0.228

3.0(2.1-4.8)

4.1(3.2-4.8)

0.136

4.1(3.2-4.8)

4.4(3.5-4.5)

0.801

Lubrication

4.5(3.2-5.1)

4.8(3.0-5.1)

0.432

4.2(3.0-4.8)

4.8(3.0-5.1)

0.244

4.7(3.7-5.1)

4.8(3.2-5.1)

0.933

Orgasm

4.0(3.2-4.8)

4.2(3.2-4.8)

0.602

4.0(2.6-4.8)

4.2(3.2-4.8)

0.609

4.0(3.5-4.8)

4.2(3.3-5.1)

0.721

Satisfaction

4.4(4.0-4.8)

4.4(4.0-4.8)

0.762

4.0(4.0-4.4)

4.4(2.8-4.8)

0.042

4.4(4.0-4.9)

4.0(3.6-4.7)

0.125

Pain

4.0(2.8-4.8)

3.6(2.8-4.8)

0.895

4.0(3.2-4.8)

4.0(2.8-4.8)

0.855

3.8(2.7-4.8)

3.4(2.5-4.4)

0.754

Total

19.6 (17.9-21.2)

20.1 (18.9-21.7)

0.351

19.3 (17.4-20.9)

20.7 (18.9-22.9)

0.045

20.0 (18.9-21.7)

19.9 (18.7-20.4)

0.505

  1. Values are presented as median and IQR (interquartile range)
  2. FSFI, Female Sexual Function Index RATV, robotic-assisted transvaginal specimen extraction surgery; RATA, robotic-assisted transvanal specimen extraction surgery